Saturday, October 06, 2018 10:57:48 AM
I invested in AMRN because I believed in the science (scientist by training), even when naysayers talked down the price up until the day their amazing results were released. It was way undervalued until it succeeded. I invested in NWBO 1 1/2 years ago (at $0.20) and have continued to accumulate (even sold some AMRN to buy more) - I do this because I believe in the DCVAX science. This is not a scam, and the stock is way undervalued. They have top notch researchers who invented it and are convinced it works, and a peer-reviewed blinded publication giving strong clues about what the results will be. In a worst case scenario, I cannot see this failing to be approved eventually just on extended OS in a subgroup, given the new FDA attitude. Maybe DCVAX Direct will succeed long-term as well, even if DCVAX L fails totally for some reason, or maybe they both succeed. I have 150,000 shares now, and will keep adding more after the AMRN price goes up more following the AHA conference in November. I also feel like my NWBO shares are almost "free shares", with a good chance of a price increase of 10X+ within the next year. If not, lesson learned, but I still feel like it was a good bet. I am hoping lightning strikes twice (AMRN and NWBO).
Recent NWBO News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
